Doximity, Inc. (DOCS)
NYSE • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Doximity, Inc. keeps $16 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 11 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Doximity missed on adjusted EPS but beat revenue in the first fiscal quarter of 2027, based on preliminary results reported Aug. 6. Revenue rose about 7% to roughly $156.6 million from $145.9 million a year ago, topping the about $151.8 million consensus by about 3%. Adjusted EPS of $0.29 missed the $0.30 estimate by about 4% and was down about 19% from $0.36 a year ago, while net income fell about 54% to roughly $24.3 million from $53.3 million. Gross profit came to about $132.9 million, with gross margin near 85%, and operating income was roughly $33.6 million as operating margin held around 22%. Operating cash flow was about $42.0 million, and the company repurchased roughly $91.6 million of stock. For the next period, consensus calls for EPS of $0.36 on revenue of $171.8 million.
Next report — what to expect
Doximity, Inc. (DOCS) reports on November 5, 2026. Wall Street is looking for consensus EPS of $0.349 on consensus revenue of $170.8 million. For trailing context, revenue grew +7.3% year over year last quarter. DOCS has beaten EPS in 6 of 8 most recent quarters.
About Doximity, Inc.
Doximity, Inc. operates a digital platform for healthcare practitioners and sells software and related services within healthcare information services. The company, listed on the NYSE as DOCS, generated $644.9 million in FY2026 revenue, with its business centered on the United States healthcare market and customers that include pharmaceutical companies and healthcare organizations.
Today's Snapshot
DOCS closed 0.9% below yesterday's close, in line with a weaker sector. Shares changed hands at about half of its usual level. Levi & Korsinsky, a law firm, reminded Doximity investors of an upcoming class-action deadline.
Trading Volume
Below 10d avg (2.9M)
1.5M
vs S&P 500 Today
Moderate Underperformance
-0.34%
Updated: October 23, 2026 at 20:16 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$26.88 - $32.01Buy
- RSI (14)72.38Sell
- Stochastic %K (14, 3, 3)89.20Sell
- MACD Level (12, 26)1.83Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.